The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Implanet sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Implanet SA (Implanet) is a medical device company that designs, manufactures and markets orthopaedic products. The company offers spine, knee and arthroscopy products. Its spine products are used for the treatment of spinal disorders and spinal fusion surgery. Implanet offers resorbable anchors system; ligament anchor; buttons for femoral fixation; resorbable interference screws; posterior fixation; and primary total knee prosthesis products. It provides complete, simple and reliable implant solutions to all surgeons. It serves across Australia, Belgium, Brazil, Canary Islands, Colombia, Cyprus, England, Germany, Greece, Italy, Iran, Peru, Russia, Saudi Arabia, South Africa, Spain, Switzerland, Tunisia, and others. Implanet is headquartered in Bordeaux, France. Key subsidiaries of Implanet include Implanet America.
The key metrics of Implanet related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Implanet is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Implanet.
For a detailed understanding of the performance of Implanet, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
